Devices

The focus on molecular imaging is facilitating a more personalized approach to medicine by visualizing specific disease pathways in individual patients. This technological shift is driving a profound transformation across the global healthcare landscape as diagnostic precision becomes the primary

The rapid evolution of medical technology has fundamentally changed how radiologists approach patients with metallic implants. Clinical safety protocols rely on a rigorous verification process known as the identification pyramid, which prioritizes the physical implant card as the definitive source

Many patients interact with AI symptom checkers that have never undergone federal review for clinical accuracy, highlighting a critical gap in consumer understanding of regulated software. The Food and Drug Administration is currently at a crossroads as it seeks to overhaul its traditional

The three-year stall of Harbin Sirui Medical’s STAR Market registration highlights the increasing regulatory skepticism regarding the long-term innovative status and financial health of domestic medical device startups. This institutional caution signals a broader structural transformation within

A new diagnostic system called CF SWIFT utilizes flexible skin stickers and a smartphone camera to measure chloride levels for approximately one dollar per test. This breakthrough represents a significant shift in medical accessibility, particularly for patients in underserved regions where

The financial sustainability of the organization is currently bolstered by non-dilutive government funding, including a substantial A$1.694 million research and development tax refund. This significant capital injection arrives at a vital moment as Optiscan Imaging Limited (ASX: OIL) moves beyond